371,709 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Strs Ohio

Strs Ohio acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 371,709 shares of the company’s stock, valued at approximately $30,001,000.

Other institutional investors have also bought and sold shares of the company. N.E.W. Advisory Services LLC bought a new stake in GE HealthCare Technologies during the first quarter valued at $25,000. Bogart Wealth LLC boosted its position in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its position in GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after acquiring an additional 222 shares during the last quarter. Ameriflex Group Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter valued at $31,000. Finally, Olde Wealth Management LLC bought a new stake in GE HealthCare Technologies during the first quarter valued at $35,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 2.6%

GEHC opened at $77.96 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a market capitalization of $35.59 billion, a PE ratio of 15.98, a P/E/G ratio of 2.90 and a beta of 1.13. The company’s 50-day moving average is $74.45 and its 200 day moving average is $73.76.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the business posted $1.00 EPS. The firm’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of research analyst reports. Morgan Stanley cut their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 31st. Citigroup upped their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. Finally, Zacks Research raised shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.